Literature DB >> 10323324

Scale development and Guy's Neurological Disability Scale.

B Sharrack, R A Hughes.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10323324     DOI: 10.1007/s004150050340

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.

Authors:  E L J Hoogervorst; P de Jonge; B Jelles; F J Huyse; I Heeres; H M van der Ploeg; B M J Uitdehaag; C H Polman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Adversarial growth in patients with multiple sclerosis and their partners: relationships with illness perceptions, disability and distress.

Authors:  Katie Ackroyd; Dónal G Fortune; Siân Price; Stephen Howell; Basil Sharrack; Claire L Isaac
Journal:  J Clin Psychol Med Settings       Date:  2011-12

3.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

4.  Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia.

Authors:  Camiel Verhamme; Ivo N van Schaik; Johannes H T M Koelman; Rob J de Haan; Marinus Vermeulen; Marianne de Visser
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

5.  One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Authors:  E L J Hoogervorst; M J Eikelenboom; B M J Uitdehaag; C H Polman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

6.  Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial.

Authors:  Cindy L Cooper; Daniel Hind; Glenys D Parry; Claire L Isaac; Munyaradzi Dimairo; Alicia O'Cathain; Anita Rose; Jennifer V Freeman; Leonie Martin; Eva C Kaltenthaler; Anna Thake; Basil Sharrack
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

7.  Neuropathic Pain in Guillain-Barre Syndrome: Association with Rehabilitation Outcomes and Quality of Life.

Authors:  Tripti Swami; Meeka Khanna; Anupam Gupta; Navin B Prakash
Journal:  Ann Indian Acad Neurol       Date:  2020-11-07       Impact factor: 1.383

8.  A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.

Authors:  Paul Wicks; Stacey McCaffrey; Kim Goodwin; Ryan Black; Michael Hoole; James Heywood
Journal:  J Med Internet Res       Date:  2019-01-25       Impact factor: 5.428

9.  Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5.

Authors:  Cheng-Ta Chou; Bing-Wen Soong; Kon-Ping Lin; Yu-Shuen Tsai; Kang-Yang Jih; Yi-Chu Liao; Yi-Chung Lee
Journal:  Ann Clin Transl Neurol       Date:  2020-03-22       Impact factor: 4.511

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.